Please Wait.....
Report
Pediatric Vaccines: Global Markets
Market Research Report I 2022-09-09 I 110 Pages I BCC Research
Description
Report Scope:
This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections through 2027 and estimates market shares for key players, as well as pediatric vaccines by type and by application. The report also discusses the impact of the COVID-19 pandemic on this market.
Report Includes:
- 21 data tables and 17 additional tables
- A comprehensive overview of the current and future global markets for pediatric vaccines
- Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size for pediatric vaccines in USD million values, market forecast and corresponding market share analysis by technology, disease type (application), and geographic region
- Highlights of the key growth driving factors and constraints that will shape the market for pediatric vaccines as the basis for projecting demand over the forecast period (2022-2027)
- In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, regulatory aspects, and other macroeconomics factors affecting the marketplace
- Highlights of the COVID-19 impact on the global pediatric vaccines market, with pandemic implications on demand/supply of vaccines across the world, and govt. strategic decisions to boost the marketplace
- Emphasis on the new developments in the pediatric vaccines market, and underlying clinical trials for all phases and list of vaccines
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
- Company profiles of major players within the industry, including Pfizer, Abbott Laboratories, Merck & Co., GlaxoSmithKline, Sanofi SA and AstraZeneca
Executive Summary
Summary:
Vaccines are one of the most significant advances in global health and are the most cost-effective strategy to reduce child mortality. Vaccines help to prevent 2 million to 3 million deaths each year. Yet, each year millions of children are left out of vaccine distribution, mostly in less developed regions. The COVID-19 pandemic also affected the pediatric immunization schedules. As per WHO, the vaccine coverage dipped for major vaccines such as those for diphtheria, tetanus and pertussis, measles, mumps and varicella, BCG and hepatitis. The dip in coverage led to outbreaks of vaccine-preventable diseases in some regions. As a result, organizations such as Gavi, UNICEF and WHO have started taking measures to increase the pediatric vaccine coverage.
Pneumococcal, meningococcal, combination vaccine (hexavalent vaccine) and COVID-19 have been approved. In 2021, vaccines such as Comirnaty from Pfizer/BioNTech, Spikevax from Moderna, CoronaVac from Sinovac, vaccines from the China National Pharmaceutical Group (Sinopharm), ZyCoV-D from Zydus Cadila (India) and Covaxin from Bharat Biotech (India) have been approved for the pediatric population. Other drivers contributing to the market include government support, growing investments and R&D budgets, collaboration agreements, and the increasing incidence and burden of diseases.
The global market for pediatric vaccinations was estimated at $REDACTED in 2021, and the market is expected to increase to nearly $REDACTED through 2027, growing at a compound annual growth rate (CAGR) of REDACTED% during the forecast period.
In this report, the market is segmented based on technology, disease type and region. The North American market currently holds the highest market share, followed by REDACTED. Major players in the global market include Pfizer, Merck, GlaxoSmithKline and Sanofi.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst's Credentials
1.8 BCC Custom Research
1.9 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Technology Background
3.1 Introduction
3.1.1 History of Vaccine Development
3.1.2 Types of Vaccines
3.1.3 Attenuated (Live) Vaccines
3.1.4 Inactivated (Killed) Vaccines
3.1.5 Toxoid Vaccines
3.1.6 Subunit Vaccines
3.1.7 Conjugate Vaccines
3.1.8 Recombinant Vector Vaccines
3.1.9 DNA Vaccines
3.1.10 RNA Vaccines
3.1.11 Childhood Vaccination Policies
3.1.12 Pediatric Immunization
3.2 Regulatory Aspects
3.2.1 New Product Approvals
Chapter 4 Market Dynamics
4.1 Factors Affecting the Pediatric Vaccine Market
4.2 Market Drivers
4.2.1 Increasing Awareness and Government Support
4.2.2 Growing Investments and R&D
4.2.3 Product Approvals and Launches
4.2.4 Collaboration Agreements
4.2.5 Increasing Burden of Diseases
4.3 Market Restraints
4.3.1 Investment and Pricing
4.4 Market Opportunities
4.4.1 Increased Demand from Emerging Markets
Chapter 5 Impact of COVID-19 Pandemic
5.1 Introduction
5.2 Epidemiology
5.3 Impact of COVID-19 on the Pediatric Vaccine Market
Chapter 6 Pediatric Vaccine Market, by Technology
6.1 Global Market for Pediatric Vaccines, by Technology
6.2 Live Attenuated Vaccines
6.3 Inactivated Vaccines
6.4 Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
6.5 Toxoid Vaccines
6.6 Other/Combination Vaccines
Chapter 7 Pediatric Vaccine Market, by Disease Type
7.1 Pneumococcal
7.2 Diphtheria, Tetanus and Pertussis
7.3 MMRV
7.4 HPV
7.5 Influenza
7.6 Other Diseases
Chapter 8 Pediatric Vaccine Market, by Region
8.1 Global Market for Pediatric Vaccines, by Region
8.2 North America
8.2.1 United States
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 United Kingdom
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia-Pacific
8.5 Rest of the World
Chapter 9 New Developments
9.1 Phase I Clinical Trials
9.2 Phase II Clinical Trials
9.3 Phase III Clinical Trials
Chapter 10 Competitive Landscape
10.1 Market Shares of Pediatric Vaccine Companies
10.2 Strategic Initiatives
Chapter 11 Company Profiles
ABBOTT LABORATORIES
ASTRAZENECA PLC
BHARAT BIOTECH INTERNATIONAL LTD.
CSL SEQIRUS UK LTD.
EMERGENT BIOSOLUTIONS INC.
GLAXOSMITHKLINE
MERCK & CO, INC.
PANACEA BIOTEC LTD.
PFIZER INC.
SANOFI S.A.
SERUM INSTITUTE OF INDIA LTD.
SINOVAC BIOTECH LTD.
List of Tables
Summary Table B : Global Market for Pediatric Vaccines, by Region, Through 2027
Summary Table A : Global Market for Pediatric Vaccines, Through 2027
Table 1 : Pros and Cons of Attenuated (Live) Vaccines
Table 2 : Pros and Cons of Inactivated (Killed) Vaccines
Table 3 : Pros and Cons of Toxoid Vaccines
Table 4 : Pros and Cons of Subunit Vaccines
Table 5 : Pros and Cons of Conjugate Vaccines
Table 6 : Pros and Cons of Recombinant Vector Vaccines
Table 7 : Pros and Cons, DNA Vaccines
Table 8 : Pros and Cons of RNA Vaccines
Table 9 : Recommended Vaccinations for Infants and Children (Birth through 6 Years) in the U.S, 2022
Table 10 : Recommended Vaccinations for Children Age 7-18, in the U.S., 2022
Table 11 : Pediatric/VFC Vaccine Price List, 2022
Table 12 : Pediatric Influenza Vaccine Price List, 2022
Table 13 : Newly Approved Pediatric Vaccines, January 2019-July 2022
Table 14 : COVID-19 Confirmed Cases and Deaths, by WHO Region, as of August 3, 2022
Table 15 : Global Market for Pediatric Vaccines, Through 2027
Table 16 : Global Market for Pediatric Vaccines, by Technology, Through 2027
Table 17 : Global Market for Live Attenuated Pediatric Vaccines, by Region, Through 2027
Table 18 : Global Market for Inactivated Pediatric Vaccines, by Region, Through 2027
Table 19 : Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Pediatric Vaccines, by Region, Through 2027
Table 20 : Global Market for Toxoid Pediatric Vaccines, by Region, Through 2027
Table 21 : Global Market for Other and Combination Pediatric Vaccines, by Region, Through 2027
Table 22 : Global Market for Pediatric Vaccines, by Disease Type, Through 2027
Table 23 : Global Market for Pneumococcal Pediatric Vaccines, by Region, Through 2027
Table 24 : Global Market for Diphtheria, Tetanus and Pertussis Pediatric Vaccines, by Region, Through 2027
Table 25 : Global Market for MMRV Pediatric Vaccines, by Region, Through 2027
Table 26 : Global Market for HPV Pediatric Vaccines, by Region, Through 2027
Table 27 : Global Market for Influenza Pediatric Vaccines, by Region, Through 2027
Table 28 : Global Market for Pediatric Vaccines for Other Diseases, by Region, Through 2027
Table 29 : Global Market for Pediatric Vaccines, by Region, Through 2027
Table 30 : North American Market for Pediatric Vaccines, by Country, Through 2027
Table 31 : European Market for Pediatric Vaccines, by Country, Through 2027
Table 32 : Asia-Pacific Market for Pediatric Vaccines, by Country, Through 2027
Table 33 : Pediatric Vaccines in Phase I Clinical Trials
Table 34 : Pediatric Vaccines in Phase II Clinical Trials
Table 35 : Vaccines in Phase III and Registration Clinical Trials
Table 36 : Pfizer: Financial Performance, 2019-2021
List of Figures
Summary Figure A : Global Market for Pediatric Vaccines, 2020-2027
Summary Figure B : Global Market for Pediatric Vaccines, by Region, 2020-2027
Figure 1 : Global Vaccination Coverage, by Vaccine, 2021
Figure 2 : Vaccine Timeline, Since 1800s
Figure 3 : Number of Countries with Childhood Vaccination Policies, by Vaccination Classification, 2021
Figure 4 : Global Market for Pediatric Vaccines, by Technology, 2020-2027
Figure 5 : Global Market Share for Pediatric Vaccines, by Technology, 2021
Figure 6 : Global Market for Live-Attenuated Pediatric Vaccines, by Region, 2020-2027
Figure 7 : Global Market for Inactivated Pediatric Vaccines, by Region, 2020-2027
Figure 8 : Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Pediatric Vaccines, by Region, 2020-2027
Figure 9 : Global Market for Toxoid Pediatric Vaccines, by Region, 2020-2027
Figure 10 : Global Market for Other and Combination Pediatric Vaccines, by Region, 2020-2027
Figure 11 : Global Market for Pediatric Vaccines, by Disease Type, 2020-2027
Figure 12 : Global Market Share for Pediatric Vaccines, by Disease Type, 2021
Figure 13 : Global Market for Pneumococcal Pediatric Vaccines, by Region, 2020-2027
Figure 14 : Global Market for Diphtheria, Tetanus and Pertussis Pediatric Vaccines, by Region, 2020-2027
Figure 15 : Global Market for MMRV Pediatric Vaccines, by Region, 2020-2027
Figure 16 : Countries with HPV Vaccine in the National Immunization Schedule, by Income Group, 2020
Figure 17 : Global Market for HPV Pediatric Vaccines, by Region, 2020-2027
Figure 18 : Global Market for Influenza Pediatric Vaccines, by Region, 2020-2027
Figure 19 : Global Market for Pediatric Vaccines for Other Diseases, by Region, 2020-2027
Figure 20 : Global Market for Pediatric Vaccines, by Region, 2020-2027
Figure 21 : Shares of Global Market for Pediatric Vaccines, by Region, 2021
Figure 22 : North American Market for Pediatric Vaccines, by Country, 2020-2027
Figure 23 : U.S. Market for Pediatric Vaccines, 2020-2027
Figure 24 : Canadian Market for Pediatric Vaccines, 2020-2027
Figure 25 : European Market for Pediatric Vaccines, by Country, 2020-2027
Figure 26 : German Market for Pediatric Vaccines, 2020-2027
Figure 27 : U.K. Market for Pediatric Vaccines, 2020-2027
Figure 28 : French Market for Pediatric Vaccines, 2020-2027
Figure 29 : Italian Market for Pediatric Vaccines, 2020-2027
Figure 30 : Spanish Market for Pediatric Vaccines, 2020-2027
Figure 31 : Rest of Europe Market for Pediatric Vaccines, 2020-2027
Figure 32 : Asia-Pacific Market for Pediatric Vaccines, by Country, 2020-2027
Figure 33 : Chinese Market for Pediatric Vaccines, 2020-2027
Figure 34 : Japanese Market for Pediatric Vaccines, 2020-2027
Figure 35 : Indian Market for Pediatric Vaccines, 2020-2027
Figure 36 : Rest of Asia-Pacific Market for Pediatric Vaccines, 2020-2027
Figure 37 : RoW Market for Pediatric Vaccines, 2020-2027
Figure 38 : Shares of Global Market for Pediatric Vaccines, by Company, 2021
Figure 39 : Abbott Laboratories: Net Revenue, 2019-2021
Figure 40 : Abbott Laboratories: Revenue Share, by Business Segment, 2021
Figure 41 : Abbott Laboratories: Revenue Share, by Country, 2021
Figure 42 : AstraZeneca: Net Revenue, 2019-2021
Figure 43 : AstraZeneca: Revenue Share, by Business Segment, 2021
Figure 44 : AstraZeneca: Revenue Share, by Region, 2021
Figure 45 : CSL Ltd. (Seqirus): Net Revenue, 2019-2021
Figure 46 : CSL Ltd. (Seqirus): Revenue Share, by Business Segment, 2021
Figure 47 : Emergent BioSolutions: Net Revenue, 2019-2021
Figure 48 : GlaxoSmithKline: Net Revenue, 2019-2021
Figure 49 : GlaxoSmithKline: Revenue Share, by Business Segment, 2021
Figure 50 : GlaxoSmithKline: Revenue Share, by Region, 2021
Figure 51 : Merck & Co.: Annual Revenue, 2019-2021
Figure 52 : Merck & Co.: Revenue Share, by Business Segment, 2021
Figure 53 : Merck & Co.: Revenue Share, by Region, 2021
Figure 54 : Pfizer: Annual Revenue, 2019-2021
Figure 55 : Pfizer: Net Sales Share, by Business Segment, 2021
Figure 56 : Pfizer: Net Sales Share, by Region, 2021
Figure 57 : Sanofi SA: Net Revenue, 2019-2021
Figure 58 : Sanofi SA: Revenue Share, by Business Segment, 2021
Figure 59 : Sanofi SA: Revenue Share, by Region, 2021
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security